We develop shared decision-making tools which shift the entire dialogue between clinicians, patients, their families and the greater care team. We also use tools at the cutting edge of data science, enabling an individualized approach to medical research that is inherently clinically meaningful.
Whether it’s the novel use of connectivity theory or a bespoke application of risk assessment tools, we can analyze your data through a new lens. We tease out the real-world relevance of your data to inform drug development decisions and the strategic direction of future research.
Grounded in decades of research, our approach uses a modified Goal Attainment Scaling (GAS) methodology to produce patient-centered outcome measures; these are valid, reliable, and responsive measures tailor-made for the clinical trial setting.